Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse
- PMID: 20335350
- DOI: 10.1093/eurjhf/hfq017
Interleukin-1beta modulation using a genetically engineered antibody prevents adverse cardiac remodelling following acute myocardial infarction in the mouse
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources